|
25-28 March, 2012, Wilmington, Delaware |
 |
 |
 |
 New Cells, New Vaccines VI: Target to Market
An international conference organized by the International Alliance for Biological Standardization and the Fraunhofer USA Center for Molecular Biotechnology.
New Cells, New Vaccines VI, the latest conference in a series that began in 2005, will be of interest to scientists in the biotechnology and pharmaceutical industries involved in vaccine development and production, as well as academics, regulatory and public health authorities, and medical and veterinary experts. The venue and the meeting provide a perfect opportunity to interact with colleagues from industry, academia and regulatory agencies to exchange views and ideas and explore potential collaboration.
Please visite the conference website, www.ncnv.org to review planned conference sessions and for registration information.
|
|
10-11 May 2012, Baltimore, Maryland |
|
|
|
 Potential use of biomarkers of inflammation and of early immunological events to assess vaccine safety.
Organized by IABS as a satellite meeting to the NFID Annual Conference on Vaccine Research.
This meeting will bring together experts from the biological industry, academia and regulatory agencies to review the possibility of introducing new selected biomarkers in the assessment of vaccine safety at pre-clinical and early clinical stages (inflammation and early immunological events). The goal of the meeting is to facilitate the integration of recent scientific advances into vaccine regulatory processes.
Scientific Program - Information/Registration - Hotel Reservation
REGISTER NOW
|
|
26-28 September 2012, Paris, France |
|
|
|
 Alternative to Antibiotics
Organized by IABS in partnership with OIE
Antibiotics are essential tools for animal and human health and concerns over antibiotic resistance and their prudent use in animals have garnered global interest. Yet insufficient attention has been given to the scientific breakthroughs and novel technologies that provide alternatives to antibiotics.
The objectives of this symposium, which will be held at the OIE headquarters in Paris, is to highlight promising research results and novel technologies that provide alternatives to antibiotics, assess challenges associated with their commercialization and use, and provide actionable strategies to support their development.
For more information, please click HERE.
|
|
|
|
|
To the members of IABS